PG
CNMD icon

Pendal Group’s CONMED CNMD Stock Holding History

Pendal Group’s Portfolio CNMD Stock Details CNMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-15,315
Closed -$1.47M – 455
2019
Q3 		$1.47M Sell
15,315
-1,239
-7% -$116K 0.02% 242
2019
Q2 		$1.42M Buy
16,554
+902
+6% +$74.1K 0.02% 251
2019
Q1 		$1.3M Hold
15,652
– – 0.02% 264
2018
Q4 		$1M Buy
15,652
+1,006
+7% +$68.8K 0.02% 265
2018
Q3 		$1.16M Sell
14,646
-12,462
-46% -$964K 0.02% 279
2018
Q2 		$1.98M Buy
27,108
+1,108
+4% +$75.4K 0.03% 232
2018
Q1 		$1.65M Buy
26,000
+362
+1% +$21.6K 0.02% 265
2017
Q4 		$1.31M Buy
25,638
+441
+2% +$23K 0.02% 270
2017
Q3 		$1.32M Buy
25,197
+10,370
+70% +$521K 0.02% 273
2017
Q2 		$755K Buy
+14,827
New +$734K 0.01% 317

Other funds holding CNMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return

Pendal Group's CNMD Position: Q4 2019 in Review

Pendal Group sold out of CONMED (CNMD) in Q4 2019, closing a stake of 15,315 shares — an estimated $1.47M sold.

Pendal Group first reported a position in CNMD in Q2 2017 and held it in 10 quarters. The position peaked at $1.98M in Q2 2018. 264 funds tracked by Wall St. Rank hold CNMD as of Q4 2019.

  • Pendal Group reported no remaining CONMED position as of Q4 2019 after selling out during the quarter.
  • Pendal Group sold 15,315 CONMED shares in Q4 2019, an estimated $1.47M.
  • Pendal Group first reported a position in CONMED in Q2 2017 and held it in 10 quarters.
  • Pendal Group's CONMED position peaked at $1.98M in Q2 2018.
  • 264 funds tracked by Wall St. Rank held CONMED as of Q4 2019.

Based on Pendal Group's 13F filing for Q4 2019, filed 6 Feb 2020.